Skip to main content

Table 1 Demographic data at study entry for the Safety population of 32 postmenopausal Caucasian women with untreated primary breast cancer

From: Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

 

Mean ± SD

Median

(Range)

Age (yrs)

68.4 ± 7.2

67.0

(56–85)

Weight (kg)

72.6 ± 16.4

68.5

(49–120)

BMI (kg/m2)

27.2 ± 5.4

26.0

(20.1–44.6)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us